TGTX · Tg Therapeutics, Inc.

$53.48 -1.39 (-2.53%) At close · Jul 29

Market Cap

$8.19B

153.08M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael S. Weiss	CEO	$1,289,985	—	$40,593,721	—	$783,125	—	$42,666,831
Sean A. Power	CFO	$420,000	—	$939,000	—	$150,360	—	$1,509,360

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael S. Weiss	CEO	$1,392,470	—	$30,871,615	—	$233,153	—	$32,497,238
Sean A. Power	CFO	$350,200	—	$6,610,300	—	$159,341	—	$7,119,841

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael S. Weiss	CEO	$636,500	—	$8,397,186	$3,450,000	$191,040	—	$12,674,726
Sean A. Power	CFO	$340,000	—	—	$345,000	$130,560	—	$815,560

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael S. Weiss	CEO	$655,625	—	$13,488,646	—	$154,500	—	$14,298,771
Sean A. Power	CFO	$330,000	—	—	$641,000	$105,600	—	$1,076,600

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael S. Weiss	CEO	$525,000	—	$9,183,647	—	$217,969	—	$9,926,616
Sean A. Power	CFO	$315,000	—	$574,000	—	$120,842	—	$1,009,842

Key facts CIK 1001316 CUSIP 88322Q108 13F (30d) 116 filings 116 filers Visit website Investor relations